Scientists launch global registry to unlock secrets of rare TRPM3 disorders
NCT ID NCT07690111
First seen Jul 08, 2026 · Last updated Jul 09, 2026 · Updated 1 time
Summary
This study creates a worldwide registry for people with disorders caused by changes in the TRPM3 gene. Researchers will track how the disease progresses over time, including developmental delays and epilepsy, and compare the effects of different treatments. The goal is to better understand these rare conditions and improve patient care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this registry could help identify which therapies work best for TRPM3-related disorders and improve quality of life for patients.
- What could go wrong
- This is an observational registry, not a treatment trial. It collects data but does not test a new drug or therapy, so direct benefits to participants are limited.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRPM3 are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Charité- Universitätsmedizin Berlin- Neuropediatrics
RECRUITINGBerlin, State of Berlin, 13353, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••